Radiosensitivity uncertainty evaluation for the in vitro biophysical modeling of EMT6 cells

Anticancer Research

Volumn 34, Issue 8, 2014, Pages 4621-4626

  Oita, Masataka ^a,b   Uto, Yoshihiro ^b   Tominaga, Masahide ^b   Sasaki, Motoharu ^c   Hara, Yasuo ^c   Kishi, Taro ^c   Hori, Hitoshi ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Biophysical modelling; In vitro; Radiosensitivity uncertainty; Radiotherapy

Indexed keywords

ETANIDAZOLE;

ANIMAL CELL; BIOPHYSICS; BREAST TUMOR; CANCER CONTROL; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; HYPOXIC CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PREDICTION; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; TUMOR MODEL; X IRRADIATION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOPHYSICAL MODELLING; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY UNCERTAINTY; RADIOTHERAPY; TUMOR CELL LINE; UNCERTAINTY;

BIOPHYSICAL MODELLING; IN VITRO; RADIOSENSITIVITY UNCERTAINTY; RADIOTHERAPY;

ANIMALS; BIOPHYSICAL PHENOMENA; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MODELS, BIOLOGICAL; RADIATION TOLERANCE; UNCERTAINTY;

EID: 84908669475     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Oita M, Ohmori K, Obinata K, Kinoshita R, Onimaru R, Tsuchiya K, Suzuki K, Nishioka T, Ohsaka H, Fujita K, Shimamura T, Shirato H and Miyasaka K: Uncertainty in treatment of head-and-neck tumors by use of intraoral mouthpiece and embedded fiducials. Int J Radiat Oncol Biol Phys 64: 1581-1588, 2006.
2. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang TC, Fujita K, Oita M, Miyasaka K, Nishimura M and Dosaka-Akita H: Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56: 126-135, 2003.
3. Pardo-Montero J and Fenwick JD: An approach to multiobjective optimization of rotational therapy. II. Pareto optimal surfaces and linear combinations of modulated blocked arcs for a prostate geometry. Med Phys 37: 2606-2616, 2010.
4. Thariat J, Bolle S, Demizu Y, Marcy PY, Hu Y, Santini J, Bourhis J and Pommier P: New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival? Anticancer Drugs 22: 596-606, 2011.
5. Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Terashima K, Asai K, Matsumoto K and Honda H: Stereotactic body radiation therapy for stage I non-small cell lung cancer patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy. Anticancer Res 32: 4041- 4044, 2012.
6. Eisenmann S, Voigt W, Muller T and Dempke W: Sequential Xirradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro. Anticancer Res 30: 4471-4476, 2010.
7. Hayes M, Lan C, Yan J, Xie Y, Gray T, Amirkhan RH and Dowell JE: ERCC1 expression and outcomes in head and neck cancer treated with concurrent cisplatin and radiation. Anticancer Res 31: 4135-4139, 2011.
8. El Sharouni SY, Kal HB and Battermann JJ: Tumour control probability of stage III inoperable non-small cell lung tumours after sequential chemo-radiotherapy. Anticancer Res 25: 4655-4661, 2005.
9. Gluck I, Vineberg KA, Ten Haken RK and Sandler HM: Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 73: 334-340, 2009.
10. Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y and Ono K: Evaluation of hypoxic cell radiosensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Anticancer Res 26: 1261-1270, 2006.
11. Seiz M, Kohlhof P, Brockmann MA, Neumaier-Probst E, Hermes P, A VOND, Vajkoczy P, Schmieder K and Tuettenberg J: First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity. Anticancer Res 29: 3261-3267, 2009.
12. Yamazaki H, Nakamura S, Nishimura T, Kodani N, Tsubokura T, Kimoto T, Sihomi H, Aibe N, Yoshida K, Koizumi M and Kagiya T: Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report. Anticancer Res 33: 1773-1776, 2013.
13. Dasu A, Toma-Dasu I and Fowler JF: Should single or distributed parameters be used to explain the steepness of tumour control probability curves? Phys Med Biol 48: 387-397, 2003.
14. Gong J, Dos Santos MM, Finlay C, and Hillen T: Are more complicated tumour control probability models better? Math Med Biol 30: 1-19, 2013.
15. Hall EJ, Astor M, Bedford J, Borek C, Curtis SB, Fry M, Geard C, Hei T, Mitchell J, Oleinick N, Rubin J, Tu A, Ullrich R, Waldren C and Ward J: Basic radiobiology. Am J Clin Oncol 11: 220-252, 1988.
16. Harada H: How can we overcome tumor hypoxia in radiation therapy? J Radiat Res 52: 545-556, 2011.
17. Brown JM, Diehn M and Loo BW Jr.: Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 78: 323-327, 2010.
18. Lee SP, Leu MY, Smathers JB, McBride WH, Parker RG and Withers HR: Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 33: 375-389, 1995.
19. Brenner DJ, Sachs RK, Peters LJ, Withers HR and Hall EJ: We forget at our peril the lessons built into the alpha/beta model. Int J Radiat Oncol Biol Phys 82: 1312-1314, 2012.
20. Biade S, Stobbe CC and Chapman JD: The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles. Radiat Res 147: 416-421, 1997.
21. Deacon J, Peckham MJ and Steel GG: The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 2: 317-323, 1984.
22. Chapman JD: Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain? J Radiat Res 55: 2- 9, 2014.
23. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB and Rich JN: Hypoxia inducible factors in cancer stem cells. Br J Cancer 102: 789-795, 2010.
24. Brown JM and Workman P: Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res 82: 171-190, 1980.
25. Sanchez-Nieto B and Nahum AE: The delta-TCP concept: A clinically useful measure of tumor control probability. Int J Radiat Oncol Biol Phys 44: 369-380, 1999.
26. Baker F and Sanger L: The Density of Clonogenic Cells in Human Solid Tumors. Int J Cell Cloning 9: 155-165, 1991.
27. West CML, Davidson SE, Roberts SA and Hunter RD: Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer 68: 819-823, 1993.
28. Suit HD, Zietman A, Tomkinson K, Ramsay J, Gerweck L and Sedlacek R: Radiation Response of xenografts of a human squamous-cell carcinoma and a glioblastoma-multiforme - a progress report. Int J Radiat Oncol Biol Phys 18: 365-373, 1990.
29. Harting C, Peschke P, Borkenstein K, and Karger CP: Singlecell-based computer simulation of the oxygen-dependent tumour response to irradiation. Phys Med Biol 52: 4775-4789, 2007.
30. Abe C, Uto Y, Nakae T, Shinmoto Y, Sano K, Nakata H, Teraoka M, Endo Y, Maezawa H, Masunaga S, Nakata E and Hori H: Evaluation of the in vivo radiosensitizing activity of etanidazole using tumor-bearing chick embryo. J Radiat Res 52: 208-214, 2011.